Summary

Eligibility
for people ages 21 years and up (full criteria)
Location
at UCSD
Dates
study started
completion around
Principal Investigator
by Mahmoud Malas, MD (ucsd)Andrew Barleben, MD (ucsd)
Headshot of Mahmoud Malas
Mahmoud Malas

Description

Summary

Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints.

Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).

Keywords

AAA, AAA - Abdominal Aortic Aneurysm, randomized, Aortic Aneurysm, Abdominal Aortic Aneurysm, Alto Abdominal Stent Graft System, FDA Approved EVAR AAA Graft Systems

Eligibility

Locations

  • The Regents of the University of California, San Diego accepting new patients
    La Jolla California 92093 United States
  • Veterans Affairs San Diego Healthcare System accepting new patients
    San Diego California 92161 United States

Lead Scientists at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Endologix
ID
NCT05064540
Study Type
Interventional
Participants
Expecting 450 study participants
Last Updated